ArticleNature medicine2024

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus.

Surender Khurana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.